Conti A - Search Results

1

Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas.

Persani L, Beck-Peccoz P, Medri G, Conti A, Faglia G. Persani L, et al. Among authors: conti a. Neuroendocrinology. 1991 Apr;53(4):411-5. doi: 10.1159/000125749. Neuroendocrinology. 1991. PMID: 1710792

2

Vasoactive intestinal polypeptide and dopamine: effect on prolactin secretion in normal women and patients with microprolactinomas.

Conti A, Togni E, Travaglini P, Muratori M, Faglia G. Conti A, et al. Neuroendocrinology. 1987 Sep;46(3):241-5. doi: 10.1159/000124826. Neuroendocrinology. 1987. PMID: 3658111

3

Osteocalcin levels in patients with microprolactinoma before and during medical treatment.

Sartorio A, Conti A, Ambrosi B, Muratori M, Morabito F, Faglia G. Sartorio A, et al. Among authors: conti a. J Endocrinol Invest. 1990 May;13(5):419-22. doi: 10.1007/BF03350694. J Endocrinol Invest. 1990. PMID: 1974270

4

Effect of two consecutive administrations of GHRH in children with constitutional growth delay.

Sartorio A, Spada A, Conti A, Morabito F, Faglia G. Sartorio A, et al. Among authors: conti a. Eur J Pediatr. 1990 Jul;149(10):678-9. doi: 10.1007/BF01959520. Eur J Pediatr. 1990. PMID: 1976518

5

Dihydroergocriptine in management of microprolactinomas.

Faglia G, Conti A, Muratori M, Togni E, Travaglini P, Zanotti A, Mailland F. Faglia G, et al. Among authors: conti a. J Clin Endocrinol Metab. 1987 Oct;65(4):779-84. doi: 10.1210/jcem-65-4-779. J Clin Endocrinol Metab. 1987. PMID: 3116032

6

Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.

Sartorio A, Spada A, Conti A, Grugni G, Morabito F, Faglia G. Sartorio A, et al. Among authors: conti a. J Endocrinol Invest. 1993 Feb;16(2):95-8. doi: 10.1007/BF03347656. J Endocrinol Invest. 1993. PMID: 7681861

7

Serum osteocalcin levels in patients with GH deficiency before and during GH treatment.

Sartorio A, Conti A, Guzzaloni G, Faglia G. Sartorio A, et al. Among authors: conti a. Acta Paediatr Scand. 1991 Jan;80(1):100-2. doi: 10.1111/j.1651-2227.1991.tb11739.x. Acta Paediatr Scand. 1991. PMID: 2028779 No abstract available.

8

The social outcome of adults with constitutional growth delay.

Sartorio A, Morabito F, Peri G, Conti A, Faglia G. Sartorio A, et al. Among authors: conti a. J Endocrinol Invest. 1990 Jul-Aug;13(7):593-5. doi: 10.1007/BF03348634. J Endocrinol Invest. 1990. PMID: 2229932

9

Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.

Moriondo P, Travaglini P, Nissim M, Conti A, Faglia G. Moriondo P, et al. Among authors: conti a. J Clin Endocrinol Metab. 1985 Apr;60(4):764-72. doi: 10.1210/jcem-60-4-764. J Clin Endocrinol Metab. 1985. PMID: 3919052

10

GH responsiveness to repeated GHRH or hexarelin administration in normal adults.

Sartorio A, Conti A, Ferrero S, Spada A, Faglia G. Sartorio A, et al. Among authors: conti a. J Endocrinol Invest. 1995 Oct;18(9):718-22. doi: 10.1007/BF03349794. J Endocrinol Invest. 1995. PMID: 8719303 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,772 results

Search Page

Filters